Updated:
Mangoceuticals, Inc.
Mangoceuticals, Inc. is a publicly traded Dallas firm focused on men's health supplements under CEO Dr. Jacob D. Cohen.
Mangoceuticals, Inc.
Mangoceuticals, Inc. is a publicly traded company (OTC: MGRX) focused on developing and marketing natural supplements for men's health, with a core product line around mango-based formulations for vitality and wellness. Its founding CEO, Dr. Jacob D. Cohen, along with Chief Medical Officer Dr. Gary D. Ginsberg, positions the company as a direct-to-consumer health brand rather than a capital allocator. There is no disclosed relationship to family wealth, institutional investment, or third-party capital management. The company's strategy centers on e-commerce sales in the supplement space, targeting domains like male hormone support and prostate health—over-the-counter products that aim at conditions often treated by prescription medication. Its product mix includes proprietary blends sold through its website, with no disclosed venture investments, partnership vehicles, or fund structures. Geographic focus is North America, specifically the United States, with no international offices or deployments. As a micro-cap public entity, Mangoceuticals reports quarterly financial results rather than AUM or deployment figures. Recent filings indicate ongoing operations and product expansion, but no material changes in business model or capital structure as of mid-2025. The company has not disclosed a shift toward asset management or family office services. The firm's key structural differentiator is its identity as a public operating company in the wellness sector—a rare category for an Altss profile. It has no investment committee, no external LP base, and no mandate to deploy third-party capital, distinguishing it from every family office or multi-family office on this platform. Its governance is via a corporate board, not a family council or investment advisory committee.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Dallas
Corporate office
Dallas, Texas, United States
Principals
Dr. Jacob D. Cohen
CEO
Dr. Gary D. Ginsberg
Chief Medical Officer
Sector focus
Frequently asked questions
Does Mangoceuticals manage capital for external investors?
No. Mangoceuticals is a publicly traded operating company (OTC: MGRX), not a fund manager or family office. It does not accept LP commitments, raise pooled investment vehicles, or provide investment advisory services. Its financial disclosures reflect product sales, not AUM. (per SEC filings)
Who leads investment decisions at Mangoceuticals?
The firm does not have an investment committee or CIO. Business decisions are made by its CEO, Dr. Jacob D. Cohen, within the framework of a public-company board, as disclosed in regulatory filings. (per SEC filings)
What products does Mangoceuticals sell?
Mangoceuticals sells over-the-counter natural supplements aimed at men's health, including formulations addressing vitality, hormone support, and prostate wellness. Its products are sold directly through its e-commerce platform, without pharmaceutical approvals—marketed as dietary supplements. (per the firm's website and SEC filings)
Is Mangoceuticals a family office?
No. Despite the '-ceuticals' suffix, the firm is a publicly traded consumer health company. It has no disclosed connection to any family wealth, and its corporate structure is that of a standard public entity with shareholders, not a single-family or multi-family office. (public record)
Where is Mangoceuticals headquartered?
The company is headquartered in Dallas, Texas, USA. It has no disclosed branch or international offices. (per SEC filings)
What stage of business is Mangoceuticals in?
Mangoceuticals is an early-stage public company, reporting revenues primarily from e-commerce supplement sales. It has not disclosed substantial outside investment from healthcare or pharmaceutical backers and remains a micro-cap equity with a narrow product line. (per SEC filings)
What is the difference between Mangoceuticals and a typical Altss family office profile?
Altss profiles normally cover private capital allocators—family offices, endowments, or asset managers. Mangoceuticals is a public operating company selling consumer health products, without any capital deployment or investment function. The profile exists to clarify this distinction and prevent category confusion. (Altss research)
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: